摘要
目的研究微生态调节剂在治疗肝硬化自发性细菌性腹膜炎中的作用。方法在住院病人中选择肝硬化自发性细菌性腹膜炎患者78例,随机分为治疗组40例,对照组38例。两组均给予护肝、利尿、支持、抗感染等治疗。治疗组加服微生态调节剂整肠生胶囊,每次3粒,一天三次,疗程15天,观察指标:临床症状、体征、肝功能、腹水常规及腹水细菌培养。结果两组在临床症状、体征、肝功能、腹水常规方面有显著性差异。结论微生态调节剂在治疗肝硬化自发性细菌性腹膜炎中有积极作用。
Objective To investigate the role of microbial modulator in the treatment of liver cirrhosis spontaneous bacterial peritonitis. Methods 78 cases liver cirrhosis spontaneous bacterial peritonitis patients were selected,and separated randomly into therapy group （40cases）. control group （38cases）.The same basic therapy including protect liver function, diuretics, lower portal vena pressure, albumin, treat infection were given between two groups . In additional to the basic therapy, Zheng Chang Sheng Capsule （3 capsules/time, tidx15 days ） were given to the therapy group, and 15 days as a treatment course. Clinical symptom,signs, liver function , ascites routine test and bacterium culture were compared between this two groups. Results There were significant improvement in the clinical symptom, signs abolition, ascites routine test and bacterium culture in the therapy group than that in the control group. Conclusion There are function in treatment of liver cirrhosis spontaneous bacterial peritonitis with microbial modulator.
